A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma - Concepedia

Concepedia

Publication | Open Access

A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma

DOI Full Paper Access

231

Citations

11

References

2012

Year

Peter J. Hosein, Jessica MacIntyre, Carolina Kawamura, Jennifer Cudris Maldonado, Vinicius Ernani, Arturo Loaiza‐Bonilla, Govindarajan Narayanan, Afonso Ribeiro, Lorraine Portelance, Jaime R. Merchan,

Abstract

FOLFIRINOX followed by chemoradiotherapy is feasible as neoadjuvant therapy in patients with unresectable LAPC. The R0 resection rate of 44 % in this population is promising. Further studies are warranted.

References

	Year	Citations

Page 1